Moderna Aktie

Moderna ab 0 Euro bei Finanzen invest ordern (zzgl. Spreads)

WKN DE: A2N9D9 / ISIN: US60770K1079

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>
20.11.2026 09:55:00

Moderna vs. BioNTech: Why Only 1 Is a Buy Heading Into 2027

The coronavirus pandemic turned two little-known mRNA companies into household names. Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) brought their vaccines to market, collected billions of dollars in revenue, and then watched demand fade in recent years. Both stocks fell significantly from their highs, and both companies have spent the past few years trying to prove they're more than coronavirus vaccine makers.

This year, their paths have diverged. Moderna's stock has soared as investors rushed to bet on the company's promising personalized cancer vaccine program. BioNTech, meanwhile, saw its stock price slip and prepared to say goodbye to its founders.

So, heading into 2027, which of these mRNA pioneers is the better buy?

Continue reading

Analysen zu Moderna Inc

mehr Analysen
12.05.26 Moderna Hold Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BioNTech (ADRs) 73,40 -0,94% BioNTech (ADRs)
Moderna Inc 179,72 -1,08% Moderna Inc